Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Philippe Gorry et al.|The Lancet Neurology|2015Cited by 508
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.Stéphane Hunot, Étienne C. Hirsch|PubMed|1999Cited by 409
FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,<i>In Vitro,</i>Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial CellsStéphane Hunot, Étienne C. Hirsch|Journal of Neuroscience|1999Cited by 359